Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY

R. Hughes (Cambridge, United Kingdom), R. Del Olmo (Buenos Aires, Argentina), B. Make (Denver, CO, United States of America), D. Price (Aberdeen, United Kingdom), A. Agustí (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), J. Vestbo (Manchester, United Kingdom)

Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Session: New tools for risk stratification of obstructive diseases
Session type: Oral Presentation
Number: 3759
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Hughes (Cambridge, United Kingdom), R. Del Olmo (Buenos Aires, Argentina), B. Make (Denver, CO, United States of America), D. Price (Aberdeen, United Kingdom), A. Agustí (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), J. Vestbo (Manchester, United Kingdom). Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY. 3759

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: